Global Cancer Diagnostics Market Analysis & Trends - Industry Forecast to 2025

  • ID: 3798541
  • Report
  • Region: Global
  • 166 pages
  • Accuray Research LLP
1 of 4
The Global Cancer Diagnostics Market is Poised to Grow at a CAGR of Around 11.7% Over the Next Decade to Reach Approximately $22.7 Billion by 2025

FEATURED COMPANIES

  • Abbott
  • Ambry Genetics
  • AstraZeneca plc
  • bioMeriux SA
  • C.R. Bard, Inc.
  • Eli Lilly and Company
  • MORE
This industry report analyzes the global markets for Cancer Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Global Cancer Diagnostics Market is poised to grow at a CAGR of around 11.7% over the next decade to reach approximately $22.7 billion by 2025.

The Cancer Diagnostics Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:

North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Ambry Genetics
  • AstraZeneca plc
  • bioMeriux SA
  • C.R. Bard, Inc.
  • Eli Lilly and Company
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Technology Analysis
1.5 Application Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Technically Advanced devices
3.1.2 Increase in Health care infrastucture
3.1.3 Economical and better outcome
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Cancer Diagnostics Market, By Technology
4.1 Imaging
4.1.1 Imaging Market Forecast to 2025 (US$ MN)
4.1.1.1 Computed Tomography (CT) Scan
4.1.1.1.1 Computed Tomography (CT) Scan Market Forecast to 2025 (US$ MN)
4.1.1.2 Ultrasound
4.1.1.2.1 Ultrasound Market Forecast to 2025 (US$ MN)
4.1.1.3 Magnetic Resonance Imaging (MRI) Scan
4.1.1.3.1 Magnetic Resonance Imaging (MRI) Scan Market Forecast to 2025 (US$ MN)
4.1.1.4 Mammography
4.1.1.4.1 Mammography Market Forecast to 2025 (US$ MN)
4.1.1.5 Positron Emission Tomography (PET) Scan
4.1.1.5.1 Positron Emission Tomography (PET) Scan Market Forecast to 2025 (US$ MN)
4.2 Biopsy
4.2.1 Biopsy Market Forecast to 2025 (US$ MN)
4.2.1.1 Bone Marrow Biopsy
4.2.1.1.1 Bone Marrow Biopsy Market Forecast to 2025 (US$ MN)
4.2.1.2 Endoscopic Biopsy
4.2.1.2.1 Endoscopic Biopsy Market Forecast to 2025 (US$ MN)
4.2.1.3 Needle Biopsy
4.2.1.3.1 Needle Biopsy Market Forecast to 2025 (US$ MN)
4.3 Endoscopy
4.3.1 Endoscopy Market Forecast to 2025 (US$ MN)
4.3.1.1 Colposcopy
4.3.1.1.1 Colposcopy Market Forecast to 2025 (US$ MN)
4.3.1.2 Colonoscopy
4.3.1.2.1 Colonoscopy Market Forecast to 2025 (US$ MN)
4.3.1.3 Sigmoidoscopy
4.3.1.3.1 Sigmoidoscopy Market Forecast to 2025 (US$ MN)
4.3.1.4 Bronchoscopy
4.3.1.4.1 Bronchoscopy Market Forecast to 2025 (US$ MN)
4.3.1.5 Other Endoscopy
4.3.1.5.1 Other Endoscopy Market Forecast to 2025 (US$ MN)
4.4 Tumor Biomarker Tests
4.4.1 Tumor Biomarker Tests Market Forecast to 2025 (US$ MN)
4.4.1.1 CA 19-9 Tests
4.4.1.1.1 CA 19-9 Tests Market Forecast to 2025 (US$ MN)
4.4.1.2 BRCA Tests
4.4.1.2.1 BRCA Tests Market Forecast to 2025 (US$ MN)
4.4.1.3 KRAS Mutation Tests
4.4.1.3.1 KRAS Mutation Tests Market Forecast to 2025 (US$ MN)
4.4.1.4 Anaplastic Lymphoma Kinase (ALK) Tests
4.4.1.4.1 Anaplastic Lymphoma Kinase (ALK) Tests Market Forecast to 2025 (US$ MN)
4.4.1.5 Circulating Tumor Cells (CTC) Tests
4.4.1.5.1 Circulating Tumor Cells (CTC) Tests Market Forecast to 2025 (US$ MN)
4.4.1.6 CA 125 Tests
4.4.1.6.1 CA 125 Tests Market Forecast to 2025 (US$ MN)
4.4.1.7 Prostate Specific Antigen Tests
4.4.1.7.1 Prostate Specific Antigen Tests Market Forecast to 2025 (US$ MN)
4.4.1.8 Carcinoembryonic Antigen (CEA) Tests
4.4.1.8.1 Carcinoembryonic Antigen (CEA) Tests Market Forecast to 2025 (US$ MN)
4.4.1.9 EGFR Mutation Tests
4.4.1.9.1 EGFR Mutation Tests Market Forecast to 2025 (US$ MN)
4.4.1.10 Alpha-Fetoprotein (AFP) Tests
4.4.1.10.1 Alpha-Fetoprotein (AFP) Tests Market Forecast to 2025 (US$ MN)
4.4.1.11 HER2 Tests
4.4.1.11.1 HER2 Tests Market Forecast to 2025 (US$ MN)

5 Cancer Diagnostics Market, By Application
5.1 Blood Cancer
5.1.1 Blood Cancer Market Forecast to 2025 (US$ MN)
5.2 Colorectal Cancer (CRC)
5.2.1 Colorectal Cancer (CRC) Market Forecast to 2025 (US$ MN)
5.3 Liver Cancer
5.3.1 Liver Cancer Market Forecast to 2025 (US$ MN)
5.4 Lung Cancer
5.4.1 Lung Cancer Market Forecast to 2025 (US$ MN)
5.5 Breast Cancer
5.5.1 Breast Cancer Market Forecast to 2025 (US$ MN)
5.6 Kidney Cancer
5.6.1 Kidney Cancer Market Forecast to 2025 (US$ MN)
5.7 Prostate Cancer
5.7.1 Prostate Cancer Market Forecast to 2025 (US$ MN)
5.8 Pancreatic Cancer
5.8.1 Pancreatic Cancer Market Forecast to 2025 (US$ MN)
5.9 Ovarian Cancer
5.9.1 Ovarian Cancer Market Forecast to 2025 (US$ MN)

6 Cancer Diagnostics Market, By Geography
6.1 North America
6.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
6.2 Europe
6.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
6.3 Asia Pacific
6.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
6.4 Middle East
6.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
6.5 Latin America
6.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
6.6 Rest of the World (RoW)
6.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)

7 Leading Companies
7.1 Agilent Technologies, Inc.
7.2 Roche
7.3 GE Healthcare (A Subsidiary of General Electric Company)
7.4 Abbott
7.5 Thermo Fisher Scientific, Inc.
7.6 C.R. Bard, Inc.
7.7 Becton, Dickinson and Company
7.8 Siemens Healthcare
7.9 Illumina, Inc.
7.10 Ambry Genetics
7.11 bioMeriux SA
7.12 AstraZeneca plc
7.13 Pfizer, Inc.
7.14 Eli Lilly and Company
7.15 F. Hoffmann-La Roche Ltd.

List of Tables

Table 1 Global Cancer Diagnostics Market By Geography, Market Forecast (2015-2025) (US$ MN)
Table 2 Global Cancer Diagnostics Market By Technology, Market Forecast (2015-2025) (US$ MN)
Table 3 Global Cancer Diagnostics Market By Application, Market Forecast (2015-2025) (US$ MN)
Table 4 North America Cancer Diagnostics Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 5 North America Cancer Diagnostics Market By Technology, Market Forecast (2015-2025) (US$ MN)
Table 6 North America Cancer Diagnostics Market By Application, Market Forecast (2015-2025) (US$ MN)
Table 7 Europe Cancer Diagnostics Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 8 Europe Cancer Diagnostics Market By Technology, Market Forecast (2015-2025) (US$ MN)
Table 9 Europe Cancer Diagnostics Market By Application, Market Forecast (2015-2025) (US$ MN)
Table 10 Asia Pacific Cancer Diagnostics Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 11 Asia Pacific Cancer Diagnostics Market By Technology, Market Forecast (2015-2025) (US$ MN)
Table 12 Asia Pacific Cancer Diagnostics Market By Application, Market Forecast (2015-2025) (US$ MN)
Table 13 Middle East Cancer Diagnostics Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 14 Middle East Cancer Diagnostics Market By Technology, Market Forecast (2015-2025) (US$ MN)
Table 15 Middle East Cancer Diagnostics Market By Application, Market Forecast (2015-2025) (US$ MN)
Table 16 Latin America Cancer Diagnostics Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 17 Latin America Cancer Diagnostics Market By Technology, Market Forecast (2015-2025) (US$ MN)
Table 18 Latin America Cancer Diagnostics Market By Application, Market Forecast (2015-2025) (US$ MN)
Table 19 RoW Cancer Diagnostics Market By Country, Market Forecast (2015-2025) (US$ MN)
Table 20 RoW Cancer Diagnostics Market By Technology, Market Forecast (2015-2025) (US$ MN)
Table 21 RoW Cancer Diagnostics Market By Application, Market Forecast (2015-2025) (US$ MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Abbott
- Agilent Technologies, Inc.
- Ambry Genetics
- AstraZeneca plc
- Becton, Dickinson and Company
- C.R. Bard, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GE Healthcare (A Subsidiary of General Electric Company)
- Illumina, Inc.
- Pfizer, Inc.
- Roche
- Siemens Healthcare
- Thermo Fisher Scientific, Inc.
- bioMeriux SA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll